ISP-001: Sleeping Beauty Transposon-Engineered B Cells for MPS I
ISP-001: Sleeping Beauty Transposon-Engineered B Cells for MPS I
Recruiting · NCT05682144 · Registry updated 2026-07-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ISP-001: Sleeping Beauty Transposon-Engineered B Cells for MPS I | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Mucopolysaccharidosis I, Nutritional and Metabolic Diseases, Skin and Connective Tissue Diseases, connective tissue disorder, cutaneous mucinosis, hereditary disease, inborn carbohydrate metabolic disorder, inborn errors of metabolism, lysosomal storage disease, metabolic disease, mucopolysaccharidosis | Recruiting | Phase 1 | 2026-07-17 | NCT05682144 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Immusoft of CA, Inc. | 1 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| UCSF Benioff Children's Hospital Oakland | Oakland | United States | 85 |
| University of Minnesota | Minneapolis | United States | 325 |